Inflammatory Reaction After Aflibercept Intravitreal Injections Associated With Silicone Oil Droplets Released From Syringes: A Case-Control Study
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVE: To determine factors causing inflammation after intravitreal aflibercept injections. PATIENTS AND METHODS: This case-control study included aflibercept-treated eyes with inflammation post-injection and aflibercept-treated control eyes. Medical records were analyzed to identify contributing factors. Biophysical tests were performed to characterize properties of particle aggregation. Institutional review board approval was obtained. RESULTS: Inflammation developed in six eyes; three patients had anterior uveitis, and five had vitreous cells. Oil droplets were seen in all cases. Saldanha Rodrigues (SR) syringes were used in all cases. Among controls, SR and Becton-Dickinson syringes were used in 10 and 17 eyes, respectively. Regression analysis showed an association between SR syringes and inflammation (odds ratio = 21.66; 95% confidence interval, 1.10–425.06; P = .043). Biophysical analyses primarily showed aggregation possibly from free oil droplets or protein-oil droplet aggregation. CONCLUSIONS: Post-injection inflammation was associated with SR syringes. Silicone oil droplets, especially after syringe agitation, might play a role in the inflammatory reaction. [ Ophthalmic Surg Lasers Imaging Retina . 2019;50:288–294.]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We have also published a case–control study that associated inflammation after intravitreal injection of aflibercept and the use of a specific syringe brand, Saldanha-Rodrigues (SR) syringes [56].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [56]
In the citing paper
“In this series of patients, inflammation occurred in all patients who received intravitreal injection after agitation of the SR syringe by flicking prior to injection. The control group that received aflibercept injection with the SR syringe and no agitation did not develop inflammation [56].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [56]
In the citing paper
“Protein aggregation or change in conformation has been studied more recently as a possible etiology of sterile uveitis/endophthalmitis [55, 56].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [56]
In the citing paper
“This contributes to SO release and this maneuver is unnecessary due to the amount of drug in the original vial [55, 56].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [56]
Citations
Cites
Schuck, P. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76713-0 · Cited by 3,868
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Wells, J. A., Glassman, A. R., Ayala, A. R., Jampol, L. M., Bressler, N. M., Bressler, S. B., Brucker, A. J., Ferris, F. L., Hampton, G. R., Jhaveri, C., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.02.022 · Cited by 1,051
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Protein Aggregation and Particle Formation in Prefilled Glass Syringes
Gerhardt, A., Mcgraw, N. R., Schwartz, D. K., Bee, J. S., Carpenter, J. F., & Randolph, T. W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23973 · Cited by 197
Analytical ultracentrifugation for the study of protein association and assembly
Howlett, G. J., Minton, A. P., & Rivas, G. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.08.017 · Cited by 180
Effects of Syringe Material and Silicone Oil Lubrication on the Stability of Pharmaceutical Proteins
Krayukhina, E., Tsumoto, K., Uchiyama, S., & Fukui, K. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24184 · Cited by 158
Anti-VEGF Therapy and the Retina: An Update
Tah, V., Orlans, H. O., Hyer, J., Casswell, E., Din, N., Sri Shanmuganathan, V., Ramskold, L., & Pasu, S. (2015) · Journal of Ophthalmology · doi:10.1155/2015/627674 · Cited by 124
Protein Particulate Detection Issues in Biotherapeutics Development—Current Status
Das, T. K. (2012) · AAPS PharmSciTech · doi:10.1208/s12249-012-9793-4 · Cited by 124
Analytical Ultracentrifugation of Complex Macromolecular Systems
Hansen, J. C., Lebowitz, J., & Demeler, B. (1994) · Biochemistry · doi:10.1021/bi00249a001 · Cited by 114
Cited by
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab
Witkin, A. J., Hahn, P., Murray, T. G., Arevalo, J. F., Blinder, K. J., Choudhry, N., Emerson, G. G., Goldberg, R. A., Kim, S. J., Pearlman, J., et al. (2020) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126420930863 · Cited by 183
“1 (2-78) 1018 Type of injections prior to brolucizumab, % Ranibizumab Bevacizumab Aflibercept 16 23 61 Most recent injection prior to brolucizumab, No.”
BackgroundAnderson, W. J., da Cruz, N. F. S., Lima, L. H., Emerson, G. G., Rodrigues, E. B., & Melo, G. B. (2021) · International Journal of Retina and Vitreous · doi:10.1186/s40942-021-00307-7 · Cited by 155
Self-citationMelo, G. B., Cruz, N. F. S. D., Emerson, G. G., Rezende, F. A., Meyer, C. H., Uchiyama, S., Carpenter, J., Shiroma, H. F., Farah, M. E., Maia, M., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100862 · Cited by 114
Self-citationRelease of silicone oil droplets from syringes
Melo, G. B., Dias Junior, C. D. S., Carvalho, M. R., Cardoso, A. L., Morais, F. B., Figueira, A. C. M., Lima Filho, A. A. S., Emerson, G. G., & Maia, M. (2019) · International Journal of Retina and Vitreous · doi:10.1186/s40942-018-0153-8 · Cited by 50
Self-citationRelease of silicone oil and the off-label use of syringes in ophthalmology
Melo, G. B., Emerson, G. G., Dias Jr, C. S., Morais, F. B., Lima Filho, A. D. S., Ota, S., Farah, M. E., Rodrigues, E. B., Maia, M., & Belfort Jr, R. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-313823 · Cited by 48
Self-citation
Metadata
- Authors
- Melo, G. B., Figueira, A. C. M., Batista, F. A. H., Filho, A. A. S. L., Rodrigues, E. B., Belfort, R., & Maia, M.
- ORCID
- Venue
- Ophthalmic Surgery, Lasers and Imaging Retina
- Publisher
- SLACK, Inc.
- Published
- 2019-05
- Volume
- 50
- Issue
- 5
- Pages
- 288-294
- ISSN
- 1542-8877 (ISSN-L)
- 2325-8160
- 2325-8179
- OpenAlex
- W2944838373
- Cited by
- 51
- References
- 20
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 11 · 2023: 3 · 2022: 6 · 2021: 9 · 2020: 12 · 2019: 3
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Ophthalmic surgery, lasers & imaging retina (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- aflibercept, intravitreal injection, silicone oil droplets, syringe design, anterior uveitis, vitreous cells, particle aggregation
- MeSH terms
- Slit Lamp Microscopy, Female, Humans, Male, Middle Aged, Recombinant Fusion Proteins, Retinal Diseases, Silicone Oils, Syringes, Uveitis, Visual Acuity, Case-Control Studies, Receptors, Vascular Endothelial Growth Factor, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammatory Reaction After Aflibercept Intravitreal Injections Associated With Silicone Oil Droplets Released From Syringes: A Case-Control Study. https://app.cochat.ai/papers/10.3928/23258160-20190503-05
- The paper
- Melo, G. B., Figueira, A. C. M., Batista, F. A. H., Filho, A. A. S. L., Rodrigues, E. B., Belfort, R., & Maia, M. (2019). Inflammatory Reaction After Aflibercept Intravitreal Injections Associated With Silicone Oil Droplets Released From Syringes: A Case-Control Study. Ophthalmic Surgery, Lasers and Imaging Retina. https://doi.org/10.3928/23258160-20190503-05
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.